NO20044645L - Substituerte amino-isoksazolinderivater og deres anvendelse som antidepressive midler - Google Patents

Substituerte amino-isoksazolinderivater og deres anvendelse som antidepressive midler

Info

Publication number
NO20044645L
NO20044645L NO20044645A NO20044645A NO20044645L NO 20044645 L NO20044645 L NO 20044645L NO 20044645 A NO20044645 A NO 20044645A NO 20044645 A NO20044645 A NO 20044645A NO 20044645 L NO20044645 L NO 20044645L
Authority
NO
Norway
Prior art keywords
substituted amino
isoxazoline derivatives
antidepressants
formula
optionally substituted
Prior art date
Application number
NO20044645A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Ignacio Andres-Gil
Margaretha Henrica Maria Bakker
Manuell Jesus Alcazar-Vaca
Ana Isabel De Lucas Olivares
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20044645L publication Critical patent/NO20044645L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20044645A 2002-04-02 2004-10-27 Substituerte amino-isoksazolinderivater og deres anvendelse som antidepressive midler NO20044645L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076239 2002-04-02
PCT/EP2003/003245 WO2003082878A1 (en) 2002-04-02 2003-03-27 Substituted amino isoxazoline derivatives and their use as anti-depressants.

Publications (1)

Publication Number Publication Date
NO20044645L true NO20044645L (no) 2004-10-27

Family

ID=28459528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044645A NO20044645L (no) 2002-04-02 2004-10-27 Substituerte amino-isoksazolinderivater og deres anvendelse som antidepressive midler

Country Status (24)

Country Link
US (1) US7265103B2 (pl)
EP (1) EP1492796B1 (pl)
JP (1) JP4580653B2 (pl)
KR (1) KR20040093061A (pl)
CN (1) CN100349897C (pl)
AR (1) AR039207A1 (pl)
AT (1) ATE372342T1 (pl)
BR (1) BR0308309A (pl)
CA (1) CA2480113C (pl)
DE (1) DE60316134T2 (pl)
DK (1) DK1492796T3 (pl)
EA (1) EA008189B1 (pl)
ES (1) ES2292949T3 (pl)
HK (1) HK1080072A1 (pl)
HR (1) HRP20040871A2 (pl)
IL (2) IL164341A0 (pl)
MX (1) MXPA04008626A (pl)
NO (1) NO20044645L (pl)
NZ (1) NZ536109A (pl)
PL (1) PL211708B1 (pl)
PT (1) PT1492796E (pl)
TW (1) TWI286138B (pl)
WO (1) WO2003082878A1 (pl)
ZA (1) ZA200407904B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200409777A (en) 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
JP4478570B2 (ja) * 2002-08-21 2010-06-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ C6−およびc9−置換’4,3−c!イソキサゾリン誘導体およびそれらの抗鬱薬としての使用
ES2331144T3 (es) 2004-11-26 2009-12-22 Janssen Pharmaceutica Nv Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada.
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
RS53416B (sr) 2009-03-10 2014-12-31 Takeda Pharmaceutical Company Limited Derivati benzofurana
US20130062732A1 (en) 2011-09-08 2013-03-14 International Business Machines Corporation Interconnect structures with functional components and methods for fabrication
CN105801510A (zh) * 2016-04-08 2016-07-27 李勇 一种治疗抑郁症的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2055011T3 (es) 1988-09-19 1994-08-16 Akzo Nv Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
EP0874833A1 (en) * 1996-01-05 1998-11-04 Hoechst Marion Roussel, Inc. 4,5-dihydronaphth 1,2-c]isoxazoles and derivatives thereof having cns activity
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
CA2437505C (en) * 2001-02-21 2010-02-09 Janssen Pharmaceutica N.V. Isoxazoline derivatives as anti-depressants
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
JP4478570B2 (ja) * 2002-08-21 2010-06-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ C6−およびc9−置換’4,3−c!イソキサゾリン誘導体およびそれらの抗鬱薬としての使用

Also Published As

Publication number Publication date
CN100349897C (zh) 2007-11-21
HK1080072A1 (zh) 2006-04-21
ZA200407904B (en) 2005-10-20
IL164341A0 (en) 2005-12-18
MXPA04008626A (es) 2004-12-06
AR039207A1 (es) 2005-02-09
CN1642960A (zh) 2005-07-20
NZ536109A (en) 2006-06-30
TWI286138B (en) 2007-09-01
CA2480113C (en) 2012-04-24
HRP20040871A2 (en) 2005-04-30
IL164341A (en) 2009-06-15
PT1492796E (pt) 2007-11-16
DE60316134T2 (de) 2008-05-29
BR0308309A (pt) 2004-12-28
CA2480113A1 (en) 2003-10-09
DE60316134D1 (de) 2007-10-18
EA200401297A1 (ru) 2005-02-24
WO2003082878A1 (en) 2003-10-09
TW200406414A (en) 2004-05-01
PL211708B1 (pl) 2012-06-29
EP1492796B1 (en) 2007-09-05
JP2005522469A (ja) 2005-07-28
AU2003219111A1 (en) 2003-10-13
EP1492796A1 (en) 2005-01-05
EA008189B1 (ru) 2007-04-27
US7265103B2 (en) 2007-09-04
ES2292949T3 (es) 2008-03-16
DK1492796T3 (da) 2007-12-03
ATE372342T1 (de) 2007-09-15
US20050222125A1 (en) 2005-10-06
JP4580653B2 (ja) 2010-11-17
KR20040093061A (ko) 2004-11-04
PL371630A1 (pl) 2005-06-27

Similar Documents

Publication Publication Date Title
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20081970L (no) Sulfonamidderivat med PGD2-reseptorantagonistaktivitet
NO20070336L (no) Indolderivater som histamin-reseptorantagonister
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20071703L (no) Kinazolinderivater
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20075641L (no) Kroman og kromenderivater og ders anvendelse
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
NO20062726L (no) Nye pyridazin-3(2H)-on derivater
NO20092342L (no) Azaspiroderivativater
NO20065456L (no) Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet
NO20045486L (no) Nye forbindelser og deres anvendelse
NO20044764L (no) 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20091766L (no) Spiro-piperidinderivater
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20064010L (no) Indazolderivater og farmasoytiske preparater inneholdelse slike
HUP0303751A2 (hu) N-fenil-pirimidin-amin-származékok alkalmazása hízósejt alapú betegségekhez hasonló allergiás rendellenességek kezelésére alkalmas gyógyszerkészítmények előállítására
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application